title: Proteolytic susceptibility of the central domain in chicken gizzard and skeletal muscle dystrophins.
abstract: We investigated proteolytic susceptibility of the central domain in dystrophin molecules from chicken smooth and skeletal muscles. Dystrophin-enriched preparations from both muscles were made as described in Pons et al. (Proc. Natl. Acad. Sci. USA (1990) 87, 7851-7855). These preparations contained other protein components in addition to dystrophin. Three enzymes (Staphylococcus aureus proteinase, chymotrypsin and trypsin) having different proteolytic specificities were used. Time-courses of proteinase degradation were examined by the Western immunoblot technique using a specific polyclonal serum directed against a fragment (residues 1173-1728) of the dystrophin central domain. We observed accumulation of some major proteinase-resistant fragments, in the 110-160 kDa range originating from that central region of the molecule. Cleavage patterns of the smooth and skeletal muscle preparations were quite similar, but molecular weights of the breakdown products differed slightly. Interpretation of the results was based on two predictive structural models of the dystrophin central domain (Koenig and Kunkel (1990) J. Biol. Chem. 265, 4560-4566 and Cross et al. (1990) FEBS Lett. 262, 87-90). Skip residues at the end of repeat 13 (around the 1740th residue of the dystrophin amino acid sequence), as hypothesized in the Cross model, constitute probably the most sensitive site within the dystrophin central domain for any exogenous (or even endogenous) proteinase. Variations observed between dystrophins from skeletal and smooth muscles also suggest that the structures of both dystrophins differ slightly even within the dystrophin central domain. This precise identification of proteinase-resistant dystrophin fragments of variable lengths is a first step towards further physicochemical studies on the very large and rare dystrophin molecule.
authors.affiliation: Pathologie Moléculaire du Muscle, INSERM U.300, Faculté de Pharmacie, Montpellier France.
authors.forename: N
authors.initials: N
authors.lastname: Augier
authors.forename: J
authors.initials: J
authors.lastname: Leger
authors.forename: A
authors.initials: A
authors.lastname: Robert
authors.forename: F
authors.initials: F
authors.lastname: Pons
authors.forename: J J
authors.initials: JJ
authors.lastname: Leger
authors.forename: D
authors.initials: D
authors.lastname: Mornet
mesh_terms: D000818:Animals; D015153:Blotting, Western; D002645:Chickens; D002918:Chymotrypsin / Q000378:metabolism; D016189:Dystrophin / Q000737:chemistry / Q000378:metabolism*; D005895:Gizzard, Avian / Q000737:chemistry; D008666:Metalloendopeptidases / Q000378:metabolism; D009132:Muscles / Q000737:chemistry; D010446:Peptide Fragments; D011487:Protein Conformation; D014357:Trypsin / Q000378:metabolism
chemical_list: D016189:Dystrophin; D010446:Peptide Fragments; D002918:Chymotrypsin; D014357:Trypsin; D008666:Metalloendopeptidases; C022653:auR protein, Staphylococcus aureus